[Bullous pemphigoid].
Ohyama
M
M
Department of Dermatology, Keio University School of Medicine.
Amagai
M
M
D001323:Autoantibodies; D001324:Autoantigens / Q000276:immunology; D002352:Carrier Proteins; D003094:Collagen / Q000276:immunology; D003598:Cytoskeletal Proteins; D003937:Diagnosis, Differential; D000071821:Dystonin; D006801:Humans; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009419:Nerve Tissue Proteins; D024041:Non-Fibrillar Collagens; D010391:Pemphigoid, Bullous / Q000276:immunology / Q000503:physiopathology; D010951:Plasma Exchange; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D000097805:Collagen Type XVII
D001323:Autoantibodies; D001324:Autoantigens; D002352:Carrier Proteins; D003094:Collagen; D003598:Cytoskeletal Proteins; D000071821:Dystonin; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D009419:Nerve Tissue Proteins; D024041:Non-Fibrillar Collagens; D011239:Prednisolone; D000097805:Collagen Type XVII; C486268:DST protein, human